Abacavir | List of Frontiers open access articles

Original Research

Published on 19 May 2021

Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire

in T Cell Biology

Patricia T. Illing
Andy van Hateren
Rachel Darley
Nathan P. Croft
Nicole A. Mifsud
Samuel King
Lyudmila Kostenko
Mandvi Bharadwaj
James McCluskey
Tim Elliott

Frontiers in Immunology

doi 10.3389/fimmu.2021.672737

6,406 views
12 citations

Original Research

Published on 31 Mar 2021

Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

in Inflammation Pharmacology

Víctor Collado-Díaz
Maria Ángeles Martinez-Cuesta
Maria Amparo Blanch-Ruiz
Ainhoa Sánchez-López
Patricia García-Martínez
José E Peris
Iris Usach
Maria Dolores Ivorra
Alessandra Lacetera
Sonsoles Martín-Santamaría

Frontiers in Pharmacology

doi 10.3389/fphar.2021.613449

6,015 views
4 citations

Brief Research Report

Published on 08 Oct 2021

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis

in Drugs Outcomes Research and Policies

Louvina E. van der Laan
Anthony J. Garcia-Prats
H. Simon Schaaf
Jana L. Winckler
Heather Draper
Jennifer Norman
Lubbe Wiesner
Helen McIlleron
Paolo Denti
Anneke C. Hesseling

Frontiers in Pharmacology

doi 10.3389/fphar.2021.722204

5,607 views
7 citations

Original Research

Published on 07 Jun 2023

Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine

in Drug Discovery in Bioinformatics

Toluwase Hezekiah Fatoki

Frontiers in Bioinformatics

doi 10.3389/fbinf.2023.1123307

4,655 views
13 citations

Original Research

Published on 14 Apr 2023

Abacavir use is associated with increased prothrombin conversion

in Molecular Innate Immunity

Qiuting Yan
Shengshi Huang
Wouter van der Heijden
Marisa Ninivaggi
Lisa van de Wijer
Romy de Laat-Kremers
Andre J. Van der Ven
Bas de Laat
Quirijn de Mast

Frontiers in Immunology

doi 10.3389/fimmu.2023.1182942

4,196 views
5 citations

Original Research

Published on 08 Jan 2024

In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota

in Antibiotic Resistance and New Antimicrobial drugs

Elisa Rubio-Garcia
Núria Ferrando
Núria Martin
Clara Ballesté-Delpierre
Jose M. Miró
Roger Paredes
Climent Casals-Pascual
Jordi Vila

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1306430

6,073 views
15 citations

Original Research

Published on 30 Apr 2021

Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study

in Drugs Outcomes Research and Policies

Mu-Lin Chiu
Wen-Miin Liang
Ju-Pi Li
Chi-Fung Cheng
Jian-Shiun Chiou
Mao-Wang Ho
Yang-Chang Wu
Ting-Hsu Lin
Chiu-Chu Liao
Shao-Mei Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.631480

5,013 views
9 citations

Systematic Review

Published on 23 Sep 2020

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

in Pharmacogenetics and Pharmacogenomics

Lisanne E. N. Manson
Jesse J. Swen
Henk-Jan Guchelaar

Frontiers in Pharmacology

doi 10.3389/fphar.2020.567048

19,711 views
45 citations

Review

Published on 12 Mar 2021

Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets

in Viral Immunology

Morris Madzime
Theresa M. Rossouw
Annette J. Theron
Ronald Anderson
Helen C. Steel

Frontiers in Immunology

doi 10.3389/fimmu.2021.634386

28,576 views
57 citations

Original Research

Published on 05 Apr 2024

Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone

in Brain Disease Mechanisms

Shreya H. Dhume
Kayode Balogun
Ambalika Sarkar
Sebastian Acosta
Howard T. J. Mount
Lindsay S. Cahill
John G. Sled
Lena Serghides

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1376681

3,923 views
2 citations

Original Research

Published on 06 Jun 2025

Insights into regulatory T-cell and type-I interferon roles in determining abacavir-induced hypersensitivity or immune tolerance

in Immunological Tolerance and Regulation

Marco Cardone
Hratch M. Baghdassarian
Maryam Khalaj
Kirthiram Krishnaveni Sivakumar
SuJin Hwang
Sintayehu Gebreyohannes
Kazuyo Takeda
Yura Jang
Nathan E. Lewis
Michael A. Norcross

Frontiers in Immunology

doi 10.3389/fimmu.2025.1612451

3,938 views
2 citations

Original Research

Published on 05 Apr 2022

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

in Drugs Outcomes Research and Policies

Napatrupron Koomdee
Chiraphat Kloypan
Pimonpan Jinda
Jiratha Rachanakul
Thawinee Jantararoungtong
Rattanaporn Sukprasong
Santirhat Prommas
Nutthan Nuntharadthanaphong
Apichaya Puangpetch
Maliheh Ershadian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.866903

7,337 views
7 citations

Review

Published on 25 Jan 2021

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines

in Pharmacogenetics and Pharmacogenomics

Heshu Abdullah-Koolmees
Antonius M. van Keulen
Marga Nijenhuis
Vera H. M. Deneer

Frontiers in Pharmacology

doi 10.3389/fphar.2020.595219

45,568 views
190 citations

Articles

Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire

Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis

Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine

Abacavir use is associated with increased prothrombin conversion

In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota

Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets

Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone

Insights into regulatory T-cell and type-I interferon roles in determining abacavir-induced hypersensitivity or immune tolerance

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines